Cargando…
The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial
BACKGROUND: Several animal studies have shown the protective effect of silymarin (the extract of Silybum marianum seeds) against anti-tuberculosis drug-induced hepatotoxicity (ATDH). However, the knowledge of ATDH of silymarin in humans is scarce. In this study, we aimed to clinically evaluate it. M...
Autores principales: | Talebi, Ali, Soltani, Rasool, Khorvash, Farzin, Jouabadi, Soroush Mohammadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284206/ https://www.ncbi.nlm.nih.gov/pubmed/37351038 http://dx.doi.org/10.4103/ijpvm.ijpvm_81_22 |
Ejemplares similares
-
The Effect of acetyl-L-carnitine, Alpha-lipoic Acid, and Coenzyme Q10 Combination in Preventing Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized, Double-blind, Placebo-controlled Clinical Trial
por: Hakimizad, Reza, et al.
Publicado: (2021) -
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
por: Heo, Eunyoung, et al.
Publicado: (2017) -
Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity
por: Das, Suvadra, et al.
Publicado: (2011) -
Silymarin prevents acetaminophen-induced hepatotoxicity in mice
por: Papackova, Zuzana, et al.
Publicado: (2018) -
Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019)